Table 3.
Patient | Age at LTX |
End-Stage Lung Disease |
Lung Cancer Histology |
N Stage Disease |
Therapy Post-LTX |
Recurrence | Status | OS (Months) |
---|---|---|---|---|---|---|---|---|
Patient 1 | 61 | IPF | ADK | 0 | No | No | Alive | 14 |
Patient 2 | 58 | IPF | ADK | 0 | No | No | Dead | 36 |
Patient 3 | 62 | IPF | ADK | 0 | No | No | Dead | 0 |
Patient 4 | 59 | IPF | ADK | 0 | No | No | Dead | 9 |
Patient 5 | 47 | IPF | ADK | 0 | No | No | Dead | 16 |
Patient 6 | 42 | LAM | LCC | 1 | CT + RT | No | Dead | 5 |
Patient 7 | 52 | IPF | SCC | 0 | No | Liver | Dead | 10 |
Patient 8 | 65 | IPF | ADK | 0 | No | Lung | Dead | 106 |
Patient 9 | 63 | IPF | LCC | 2 | CT | Mediastinal LN | Dead | 7 |
Patient 10 | 56 | IPF | ADK | 0 | No | Lung | Dead | 10 |
ADK: adenocarcinoma; CT: chemotherapy; IPF: idiopathic pulmonary fibrosis; LAM: lymphangioleiomyomatosis; LCC: large-cell carcinoma; LN: lymph nodes; RT: radiotherapy; SCC: squamous cell carcinoma; LTX: lung transplantation.